Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: TechSci Research | PRODUCT CODE: 1953518

Cover Image

PUBLISHER: TechSci Research | PRODUCT CODE: 1953518

Disruptive Behavior Disorder Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Treatment, By Region & Competition, 2021-2031F

PUBLISHED:
PAGES: 180 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4500
PDF and Excel (Multi-User License)
USD 5500
PDF and Excel (Custom Research License)
USD 8000

Add to Cart

We offer 8 hour analyst time for an additional research. Please contact us for the details.

The Global Disruptive Behavior Disorder Treatment Market is projected to expand from USD 1.86 million in 2025 to USD 2.57 million by 2031, registering a compound annual growth rate of 5.54%. This market encompasses various pharmaceutical and psychotherapeutic interventions aimed at managing behavioral issues such as Oppositional Defiant Disorder and Conduct Disorder. The growth trajectory is primarily supported by the increasing clinical recognition of pediatric psychiatric conditions and the adoption of strong diagnostic frameworks that allow for earlier intervention. These foundational drivers are further strengthened by growing government financial support intended to merge mental health services with primary care systems. Highlighting the significant need for therapeutic management, the World Health Organization estimates that conduct disorder will affect approximately 3.3% of adolescents aged 10-14 years globally in 2025.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 1.86 MIllion
Market Size 2031USD 2.57 MIllion
CAGR 2026-20315.54%
Fastest Growing SegmentConduct Disorder
Largest MarketNorth America

Despite these positive growth indicators, the market faces a substantial obstacle in the form of a severe global shortage of specialized child psychiatrists and mental health professionals. This lack of a sufficient workforce creates critical bottlenecks in diagnosing patients and delivering treatments, a problem that is particularly acute in developing regions. As a result, the scarce availability of trained providers limits the widespread implementation of therapeutic regimens, effectively restricting the potential market size even in the face of high clinical demand.

Market Driver

The rising prevalence of Oppositional Defiant Disorder (ODD) and Conduct Disorder (CD) acts as the main engine for market expansion, creating an urgent need to scale up therapeutic options. This increase in behavioral diagnoses reflects a wider decline in adolescent psychological well-being, fueling the demand for both medication-based and psychosocial interventions. Data from the Centers for Disease Control and Prevention's 'Youth Risk Behavior Survey Data Summary & Trends Report: 2013-2023', released in August 2024, reveals that roughly 40% of high school students experienced persistent feelings of sadness or hopelessness in 2023, emphasizing the severe need for enhanced behavioral health services. This expanding patient population forces healthcare providers to implement more aggressive diagnostic and treatment protocols to handle the increasing volume of disruptive behavioral symptoms.

Alongside this clinical demand is a significant increase in government-funded initiatives for pediatric mental health, which helps reduce barriers to care and subsidizes the cost of treatment. Both federal and state authorities are increasingly distributing grants to embed behavioral health services within schools and community centers, thereby directly widening the addressable market. For example, the Substance Abuse and Mental Health Services Administration announced in a July 2024 press release that it had awarded $15.3 million specifically to support children through school-based mental health services and aid for those with serious emotional disturbances. This surge in public investment is matched by private sector optimism; according to MedCity News in October 2024, investments in digital health startups focused on youth mental health represented 34% of all digital behavioral health funding in 2023.

Market Challenge

A severe constraint on the Global Disruptive Behavior Disorder Treatment Market is the critical global shortage of specialized child psychiatrists and mental health professionals. This deficit in the workforce creates a significant bottleneck within the healthcare delivery system because diagnosing conditions like Conduct Disorder and managing subsequent pharmaceutical or psychotherapeutic regimens demand strict supervision by licensed specialists. When the number of available professionals is insufficient to meet clinical needs, patient wait times increase dramatically, and numerous diagnoses are missed completely, effectively stopping potential patients from becoming active users of therapeutic products.

This structural limitation substantially shrinks the addressable market size, irrespective of how prevalent the disease is or how much diagnostic awareness exists. The gap in provider availability is clearly reflected in major healthcare statistics. According to the American Academy of Child and Adolescent Psychiatry, approximately 72% of counties in the United States did not have practicing child and adolescent psychiatrists in 2024. Such a profound lack of specialists implies that therapeutic interventions cannot reach a vast segment of the population, thereby impeding market revenue growth and limiting the effective scope of treatment providers.

Market Trends

The integration of Digital Therapeutics and AI-Driven Analytics is establishing software-based interventions as a reimbursed standard of care, which is fundamentally reshaping the market landscape. These prescription-grade applications employ artificial intelligence to administer cognitive behavioral therapy and track symptoms in real-time, effectively bridging the gap between clinical appointments for pediatric patients exhibiting disruptive behaviors. The commercial viability of this approach was solidified when federal regulators established formal payment structures, directly encouraging adoption by providers. In the 'Calendar Year (CY) 2025 Medicare Physician Fee Schedule Final Rule' released in November 2024, the Centers for Medicare & Medicaid Services finalized three new HCPCS codes specifically for digital mental health treatment devices, establishing a clear reimbursement pathway that incentivizes incorporating these technologies into behavioral treatment plans.

Furthermore, the expansion of home-based and outpatient care models is decentralizing psychiatric services, moving them toward remote, family-centered management and away from protocols that rely heavily on facilities. This transition is supported by tele-psychiatry infrastructure, which permits specialists to conduct behavioral parent training directly within the home setting, thereby surmounting geographic hurdles and severe provider shortages. The enduring nature of this shift in care delivery is demonstrated by utilization rates that remain high well past the initial urgency of the pandemic. According to the California Department of Public Health's 'Tele-Mental Health Care for Children' report from June 2024, the use of tele-mental health services for youth has sustained a 30-fold increase compared to pre-pandemic levels, highlighting the market's long-term reorientation toward outpatient and technology-enabled therapeutic access.

Key Market Players

  • Eli Lilly and Company
  • Pfizer Inc.
  • Johnson & Johnson
  • Boston Children's Hospital
  • INTEGRIS Health
  • H. Lundbeck A/S
  • Springwoods Behavioral Health
  • PrairieCare, LLC
  • Valley Children's Healthcare
  • Impireum Psychiatric Group

Report Scope

In this report, the Global Disruptive Behavior Disorder Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Disruptive Behavior Disorder Treatment Market, By Type

  • Oppositional Defiant Disorder
  • Conduct Disorder
  • Intermittent Explosive Disorder

Disruptive Behavior Disorder Treatment Market, By Treatment

  • Medication Management
  • Comprehensive Evaluation
  • Family Therapy
  • Parenting Modification
  • Group Therapy
  • Individual Therapy
  • Social
  • Emotional Skills Training

Disruptive Behavior Disorder Treatment Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Disruptive Behavior Disorder Treatment Market.

Available Customizations:

Global Disruptive Behavior Disorder Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Product Code: 27306

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Disruptive Behavior Disorder Treatment Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Oppositional Defiant Disorder, Conduct Disorder, Intermittent Explosive Disorder)
    • 5.2.2. By Treatment (Medication Management, Comprehensive Evaluation, Family Therapy, Parenting Modification, Group Therapy, Individual Therapy, Social, Emotional Skills Training)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Disruptive Behavior Disorder Treatment Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Treatment
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Disruptive Behavior Disorder Treatment Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Treatment
    • 6.3.2. Canada Disruptive Behavior Disorder Treatment Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Treatment
    • 6.3.3. Mexico Disruptive Behavior Disorder Treatment Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Treatment

7. Europe Disruptive Behavior Disorder Treatment Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Treatment
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Disruptive Behavior Disorder Treatment Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Treatment
    • 7.3.2. France Disruptive Behavior Disorder Treatment Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Treatment
    • 7.3.3. United Kingdom Disruptive Behavior Disorder Treatment Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Treatment
    • 7.3.4. Italy Disruptive Behavior Disorder Treatment Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Treatment
    • 7.3.5. Spain Disruptive Behavior Disorder Treatment Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Treatment

8. Asia Pacific Disruptive Behavior Disorder Treatment Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Treatment
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Disruptive Behavior Disorder Treatment Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Treatment
    • 8.3.2. India Disruptive Behavior Disorder Treatment Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Treatment
    • 8.3.3. Japan Disruptive Behavior Disorder Treatment Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Treatment
    • 8.3.4. South Korea Disruptive Behavior Disorder Treatment Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Treatment
    • 8.3.5. Australia Disruptive Behavior Disorder Treatment Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Treatment

9. Middle East & Africa Disruptive Behavior Disorder Treatment Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Treatment
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Disruptive Behavior Disorder Treatment Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Treatment
    • 9.3.2. UAE Disruptive Behavior Disorder Treatment Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Treatment
    • 9.3.3. South Africa Disruptive Behavior Disorder Treatment Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Treatment

10. South America Disruptive Behavior Disorder Treatment Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Treatment
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Disruptive Behavior Disorder Treatment Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Treatment
    • 10.3.2. Colombia Disruptive Behavior Disorder Treatment Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Treatment
    • 10.3.3. Argentina Disruptive Behavior Disorder Treatment Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Treatment

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Disruptive Behavior Disorder Treatment Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Eli Lilly and Company
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Pfizer Inc.
  • 15.3. Johnson & Johnson
  • 15.4. Boston Children's Hospital
  • 15.5. INTEGRIS Health
  • 15.6. H. Lundbeck A/S
  • 15.7. Springwoods Behavioral Health
  • 15.8. PrairieCare, LLC
  • 15.9. Valley Children's Healthcare
  • 15.10. Impireum Psychiatric Group

16. Strategic Recommendations

17. About Us & Disclaimer

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!